Affymetrix (AFFX) 7.20 $AFFX
Affymetrix (AFFX) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 9:40AM CDT
Affymetrix (AFFX) Sees Hammer Chart Pattern: Time to Buy?
CollabRx partners with Affymetrix to develop integrated clinical cancer panels
M2 - Thu Apr 17, 7:16AM CDT
CollabRx, Inc. (NASDAQ: CLRX) and Affymetrix, Inc. (NASDAQ: AFFX) said they have announced an agreement to optimize the use of CollabRx's Genetic Variant Annotation Service in connection with Affymetrix' OncoScan FFPE Assay Kit and CytoScan Cytogenetics Suite for analysis of gene copy number variation in cancer research.
CollabRx and Affymetrix Partner To Develop Analytical Tools For Integrated Clinical Cancer Panels
PRWeb - Wed Apr 16, 8:07AM CDT
CollabRx, Inc. (NASDAQ: CLRX), a leading provider of software and IT systems that support clinical decision-making in oncology, and Affymetrix, Inc. (NASDAQ: AFFX), an industry leader in genomics analysis, today announced an agreement to optimize the use of CollabRx's Genetic Variant Annotation (GVA) Service™ in connection with Affymetrix' OncoScan™ FFPE Assay Kit and CytoScan(R) Cytogenetics Suite for analysis of gene copy number variation (CNV) in cancer research.
Global SNP Genotyping and Analysis Market Forecasts & Opportunities 2013-2019
M2 - Mon Apr 14, 4:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bk2mlx/snp_genotyping) has announced the addition of the "Global SNP Genotyping and Analysis Market Forecasts & Opportunities 2013-2019" report to their offering. The global market is expected to reach USD 9,485.2 million by 2019, up from USD 2,385.2 million in 2012, growing at a CAGR of 21.8% The study elucidates the market dynamics, which are the drivers, restraints and opportunities that a market player will come across in this area. It gives a brief introduction to each topic as it covers the commercial aspects of the market and its technologies along with current trends. The report analyzes four major applications of SNP genotyping in Life Sciences and Healthcare industry which are Pharmaceutical/Pharmacogenomics, Diagnostics, Agricultural Biotechnology and Breeding and Animal Livestock. The market products are internally affected by power of substitution since there are around 8 to 10 different efficient techniques to carry out SNP genotyping such as TaqMan, SNPlex, Microarray, MALDI-TOF etc. With the completion of the Human Genome Project, over 2 million SNP's have been added to global databases which in turn have initiated a series of research and development projects to understand potential of developing diagnostic tests through rapid genotyping techniques. A considerable amount of revenue is spent on research to developing diagnostic products similar to companion diagnostics which would enable to give us a preview of how a genome would unfold as an individual grows older. There is a high intensity of research in food crops such as rice, wheat, oats, corn, maize and other grasses. SNP genotyping in agriculture gained acceptance long before other applications. The GeneChip Rice 44K array offered by Affymetrix is one of the most popular platforms for rice genotyping which identifies variants that impact yield. Fluidigm's SNPtype assays have been utilized by International Rice Research Institute which holds the world's largest ex-situ collection of rice germplasm and plays a very large role in maintaining this repository. Scope of the Report Technology - SNP GeneChips and Microarrays - Taqman Allelic Discrimination - SNP by Pyrosequencing - AB SNPlex - MassARRAY MALDI-TOF - Others Application - Pharmaceuticals and Pharmacogenomics - Diagnostic Research - Agricultural Biotechnology - Breeding and Animal Livestock Key Topics Covered: - Introduction - Executive Summary - Market Overview: Global SNP Genotyping & Analysis Market - Global SNP Genotyping & Analysis Market, by Technologies, 2011 - 2019 (USD Million) - Global SNP Genotyping and Analysis Market, by Applications, 2011 - 2019 (USD Million) - Global SNP Genotyping and Analysis Market, by Geography, 2011 - 2019 (USD Million) - Competitive Landscape - Company Profiles - Affymetrix, Inc - Douglas Scientific LLC - Fluidigm - Illumina, Inc - Life Technologies Corporation - PREMIER Biosoft - Sequenom, Inc - ThermoFisher Scientific Visit http://www.researchandmarkets.com/research/bk...genotyping
15.2% Return Seen to Date on SmarTrend Affymetrix Call (AFFX)
Comtex SmarTrend(R) - Fri Apr 11, 9:47AM CDT
SmarTrend identified a Downtrend for Affymetrix (NASDAQ:AFFX) on February 6th, 2014 at $7.53. In approximately 2 months, Affymetrix has returned 15.22% as of today's recent price of $6.38.
Awards, Conference Call Schedules, New Products, and Partnerships - Analyst Notes on Silicon Labs, Affymetrix, Methode Electronics, Itron, and Semtech
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Silicon Laboratories Inc. (NASDAQ: SLAB), Affymetrix Inc. (NASDAQ: AFFX), Methode Electronics Inc. (NYSE: MEI), Itron, Inc. (NASDAQ: ITRI), and Semtech Corp. (NASDAQ: SMTC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Global Proteomics Market (Technology, Instruments, Reagents & Services) - Global Forecast to 2018
M2 - Tue Apr 08, 6:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2hnkrt/proteomics_market) has announced the addition of the "Proteomics Market by Technology, Instruments, Reagents & Services - Global Forecast to 2018" report to their offering. The global market was valued at an estimated $10,223.3 million in 2013. The growth of this market is mainly fuelled by the increasing need for personalized medicine, growth in pharmaceutical and biotechnology research and development (R&D) expenditure, technological advancements, and availability of government and private funding for proteomics projects.The overall market is further divided into four major geographies, namely, North America, Europe, Asia, and the Rest of the World (RoW). These regions are further analyzed at the country level. This report discusses the key market drivers, restraints, and opportunities in the global proteomics market and its sub-markets. Based on reagents type, the market is segmented into protein microarray, spectroscopy, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation kits. Furthermore, the services market is sub-divided into analytical laboratory services, and data analysis and maintenance. Analytical laboratory services are further segmented into three types, namely, protein identification, protein separation, and protein sequencing. Data analysis and maintenance is further divided into bioinformatics databases and bioinformatics tools. North America accounted for the largest share of the global market in 2013, followed by Europe, Asia-Pacific, and the Rest of the World. Developed geographies like North America and Europe are likely to grow at lower CAGRs as compared to the Asian market. The growth in the Asian market is attributed to the shift of focus of the proteomics research-related industries towards Asia and the increase in both public and private funding to boost proteomic research in the region. Scope of the Report Proteomics Instrumentation Technologies - Protein Microarray - - Biochips - - Microarray instruments - Spectroscopy - - Mass spectrometry - - NMR spectrometry - - Circular dichroism (CD) spectroscopy - X-ray Crystallography - Chromatography - - HPLC Systems - - Affinity chromatography - - Ion chromatography - Supercritical Fluid Chromatography - Electrophoresis - - Gel electrophoresis - - Capillary electrophoresis - Surface Plasmon Resonance System (SPR System) - Protein Fractionation System Proteomics Reagents - Microarray - Spectroscopy - X-ray Crystallography - Chromatography - Electrophoresis - Immunoassay - Microsphere - Protein Fractionation Kits Proteomics Services - Analytical Laboratory Services - Protein Identification - Protein Separation - Protein Sequencing - Data Analysis and Maintenance - Bioinformatics Databases - Bioinformatics Tools - Global Proteomics Market, by Application - Drug Discovery - Diagnosis Key Topics Covered: - Introduction - Executive Summary - Premium Insights - Market Overview - Proteomics Instrumentation Technology - Proteomics Reagents Market - Proteomics Services Market - Proteomics Applications Market - Geographic Analysis - Competitive Landscape - Company Profiles - Thermo Fisher Scientific Inc. - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Luminex Corporation - Danaher Corporation - Ge Healthcare - Waters Corporation - Affymetrix Inc. - Perkinelmer, Inc. - Sigma-Aldrich Corp Visit http://www.researchandmarkets.com/research/2h...ics_market
Global Multiplexed Diagnostics Market (Technologies & Applications) 2013 - 2019
M2 - Tue Apr 08, 2:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m73r7s/multiplexed) has announced the addition of the "Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. This report covers the market analysis of the multiplexed diagnostics technologies namely, very high, high, medium, low density multiplexed assays & next-generation sequencing. This report contains qualitative information about oligonucleotide arrays, phage display, bacterial artificial chromosome arrays, protein arrays, bead-based arrays, antibody arrays, reverse arrays, mass spectrometry, quantitative PCR bead-based and microplate assays and next-generation sequencing. The market is also segmented on the basis of several application areas of multiplexed diagnostics, namely, infectious disease diagnosis, oncology, autoimmune diseases, cardiac conditions, allergies and others (Alzheimer's disease, diabetes, kidney toxicity and HIV). The global multiplexed diagnostics market has phenomenally increased the volume and quality of diagnostic procedures by reducing the turnaround time and analyzing multiple analytes in a single cycle and thereby resulting in rapid adoption of such techniques. The stake holders in this market include market players who provide multiplexed diagnostic assay kits, reagents, solutions and systems. The qualitative details of the market dynamics of the multiplexed diagnostics market such as drivers, restraints and opportunities that influence the current nature and future status of this field are covered under the market overview section of this report. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been provided in the market overview section of the report in order to give a thorough analysis of the overall competitive scenario in the global multiplexed diagnostics market. The market size and forecast in terms of USD million has been provided in the report for the period 2011 to 2019. This report also includes the overall market growth rate (Compounded Annual Growth Rate) of technologies, applications and geographic market for the period 2013 to 2019, considering 2012 as the base year. The global multiplexed diagnostics market is segmented as follows: Technology - Very high density multiplexed assays - - Oligonucleotide Arrays - - Phage Display - High Density Multiplexed Assays - - Bacterial Artificial Chromosome Arrays - - Protein Arrays - Medium Density Multiplexed Assays - - Bead-based Arrays - - Antibody Arrays - - Reverse Arrays - - Mass Spectroscopy - Low Density Multiplexed Arrays - - Quantitative PCR Bead-based Assays - - Microplate Assays - Next-Generation Sequencing Application - Infectious Disease Diagnosis - Oncology - Autoimmune diseases - Cardiac - Allergies - Others Key Topics Covered: - Introduction - Executive Summary - Multiplexed Diagnostics Market Overview - Global Multiplex Assays Market, by Technology - Global Multiplex Diagnostics Market, By Application - Global Multiplexed Diagnostics Market, by Geography - Recommendations - Company Profiles - Affymetrix, Inc. - Agilent Technologies, Inc. - bioMerieux, Inc. - Bio-Rad Laboratories, Inc. - Illumina, Inc. - F. Hoffman-La Roche, Ltd. - Gen-Probe, Inc. - Life Technologies Corporation - Luminex Corporation - Seegene, Inc. Visit http://www.researchandmarkets.com/research/m7...ultiplexed
Gene Expression Reagent Trends - Global Market Report 2014
M2 - Mon Apr 07, 10:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3lbtf8/gene_expression) has announced the addition of the "Gene Expression Reagent Trends" report to their offering. Gene Expression refers to the production of functional products, most commonly proteins, using information saved in a specific gene. Gene expression is a key process undertaken by all life forms, including unicellular as well as multicellular organisms, primarily for generating their macromolecular machinery. The report analyzes and presents an overview of Gene Expression Reagents market worldwide. Supported with 3 market data tables, the report provides a review of global market trends, and various strategic industry activities of major companies witnessed by the industry over the last few years. Key Topics Covered: 1. GENE EXPRESSION REAGENTS - AN OVERVIEW 2. RECENT INDUSTRY ACTIVITY - Sigma-Aldrich Inks Agreement with Olink Bioscience - Synpromics Receives Grant from Technology Strategy Board - Thermo Fisher Scientific to Acquire Life Technologies - Agilent Technologies Inks Licensing Agreement with SRI International - Agilent Technologies Inks Agreement with Roche - ZyGEM Corp Signs Agreement with Quanta BioSciences - Affymetrix Receives US FDA Clearance for Gene Profiling Reagents 3. PRODUCT LAUNCHES/TECHNOLOGICAL INNOVATIONS - Agilent Technologies Launches SureScanDx Microarray Scanner - Illumina Introduces Universal Real-Time PCR Reagent Portfolio - Life Technologies Introduces Compendia Oncomine? Next - Generation Sequencing Power Tools - Mirus Bio Develops TransIT-BrCa Transfection Reagent - Affymetrix Launches Axiom? Genotyping Arrays - Affymetrix Introduces SensationPlus FFPE Reagent Kit - Agilent Technologies Unveils Agilent SurePrint G3 Human Gene Expression v2 Microarray - Agilent Unveils Agilent CytoGenomics 1.0 - Agilent Technologies Introduces GeneSpring GX 11. - Bioinformatics Software - Agilent Technologies Unveils New Exon Analysis Solution 4. MARKET PARTICIPANTS - Affymetrix, Inc. - Agendia, Inc. - Agilent Technologies, Inc. - Applied Biosystems, Inc. - Cepheid - Clontech Laboratories, Inc. - Complete Genomics, Inc. - Cytocell Ltd. - DNA LandMarks, Inc. - DNAVision SA - Dynex Technologies, Inc. - Epicentre? Biotechnologies - Eurofins Medigenomix GmbH - Eurogentec SA - Exiqon A/S - GE Healthcare - Geneworks Pty., Ltd. - Genisphere LLC - Illumina, Inc. - Inqaba Biotechnical Industries Pty., Ltd. - Life Technologies Corporation - Mirus Bio LLC - Ocimum Biosolutions Ltd. - Origene Technologies, Inc. - Quanta Biosciences, Inc. - Roche Diagnostics - Saturn Biotech Ltd. - Sequetech Corporation - Sigma-Aldrich Co. LLC - Thermo Fisher Scientific, Inc. 5. APPENDIX For more information visit http://www.researchandmarkets.com/research/3l...expression
DNA Gene Chip Trends - Global Market Overview 2014
M2 - Mon Apr 07, 10:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c4hnrx/dna_gene_chip) has announced the addition of the "DNA Gene Chip Trends" report to their offering. DNA Gene chips or DNA microarrays are small chips that are engrafted with DNA molecules. The versatile and powerful arrays are commonly used in medicinal and genetics research due to their ability to speed up the process of research. The primary research applications include geneID, comparative genomic hybridization, profiling of gene expression as well as re-sequencing and genotyping in human, plant, prokaryotes and eukaryotes genomes. The report analyzes and presents an overview of DNA & Gene Chip market worldwide. The report in addition provides global market estimates and projections for DNA & Gene Chip (Microarray) in US dollars for years 2012 through 2017. Supported with 6 market data tables the report provides a review of market trends, types and applications DNA microarrays, the current research scenario, and alternative competitive technologies. Key Topics Covered: 1. DNA GENE CHIPS - ACCELERATING MEDICINAL AND GENETIC RESEARCH - DNA Gene Chip - An Introduction - Types of DNA Microarrays - oDNA Microarrays - Spotted cDNA Microarrays - List of Major Applications of Microarrays - Advantages of Microarray Analysis - Top 5 Major Microarray Application Areas with Increasing Demand - DNA Gene Chip Market 2. RESEARCH SCENARIO - Technological Advancements in Biological Analysis - Mitochondrial DNA Microarray for Cancer Detection - Equine Gene Chip - Opens New Possibilities in Preventive Medication 3. COMPETITIVE ALTERNATIVE TECHNOLOGIES - Next Generation Sequencing (NGS) - NGS Technologies Application Areas - Present NGS Platforms - NGS - Key Facts 4. RECENT INDUSTRY ACTIVITY - Thermo Fisher Scientific to Take Over Life Technologies 5. MARKET PARTICIPANTS - Affymetrix, Inc. - Agilent Technologies, Inc. - Applied Microarrays, Inc. - Arrayit Corporation - Biometrix Technology, Inc. - Bioneer Corporation - Bio-Synthesis, Inc. - DNA Chip Research, Inc. - DNAmicroarray, Inc. - Eppendorf AG - Eurofins MWG Operon - Exiqon A/S - Genisphere LLC - Greiner Bio-One GmbH - Illumina, Inc. - LC Sciences - Macrogen, Inc. - Microarrays, Inc. - NGK Insulators Ltd. - Ocimum Biosolutions Ltd. - Oxford Gene Technology - PamGene International BV - PerkinElmer, Inc. - Savyon Diagnostics Ltd. - Scienion AG - Thermo Fisher Scientific, Inc. - Life Technologies Corporation - Toray Industries, Inc. - Toray International UK Ltd. - Toshiba Corporation 6. APPENDIX For more information visit http://www.researchandmarkets.com/research/c4..._gene_chip
Global Genomics Market Forecasts & Opportunities to 2018 - Products, Consumables & Services
M2 - Mon Apr 07, 3:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b5sp23/genomics_market) has announced the addition of the "Global Genomics Market Forecasts & Opportunities to 2018 - Products, Consumables & Services" report to their offering. The global genomics market was valued at $11.11 billion in 2013, and is expected to grow at a CAGR of over 12.0% from 2013 to 2018. The penetration of new markets through the expansion of genomics applications, and advancements in existing technologies plays an important role in attracting new market participants to invest in this market. Next Generation Sequencing (NGS) in personalized medicine and molecular diagnostics is considered as a high growth area for the global genomics market. This new technology provides an affordable and accurate screening solution for genetic mutations. Moreover, the increasing volume of novel genetic tests for personalized medicine and biomarker discovery ensures the continued growth of this market. Tier I and Tier II companies were found to be dominant in the instrument and consumables segments of the genomics market. The genomics market is becoming increasingly consolidated. Among all market players, Roche Diagnostics, Life Technologies, and QIAGEN together accounted for over 47.0% of the revenues earned by the global genomics market in 2013. This concentration of market shares with Tier I market players is expected to challenge market growth. However, technological advancements, and increasing investments are expected to continue to drive the growth of the global genomics market. This report provides comprehensive analysis of market dynamics - drivers, restraints, key market metrics, current market trends, competitive structure, and market revenues and forecasts from 2013 to 2018. It also includes an analysis of mergers and acquisitions in the global genomics market over the last ten years, in addition to technology roadmaps for key technology areas in this market. As a part of the premium insights section, current growth strategies adopted by market participants in the global genomics market have been detailed and analyzed. Scope Products - Instruments - NGS platform - Microarray - RT-PCR Consumables - Genechips - Reagents for DNA Extraction & Purification - Sequencing Services - Sequencing & Microarray Services - Software) Key Topics Covered: - Introduction - Executive Overview - Total Global Genomics Market - Global Genomics Market, By Product Segment - Global Genomics Market, By Technology - Global Genomics Market, By Application - Global Genomics Market, By Geography - Mergers And Acquisitions - Competitive Strategies - Company Profiles - Affymetrix, Inc. - Agilent Technologies, Inc. - Bgi - Bio-Rad Laboratories, Inc. - Cepheid - Ge Healthcare - Illumina, Inc. - Life Technologies, Corp. - Qiagen - Roche Diagnostics For more information visit http://www.researchandmarkets.com/research/b5...ics_market
Affymetrix to Report First Quarter 2014 Operating Results on Thursday May 1st, 2014
Business Wire - Wed Apr 02, 5:00AM CDT
Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will report operating results for the first quarter of 2014 after market close on Thursday May 1, 2014. The company will hold a conference call on the same day at 5:00pm ET.
Latin American Bioinformatics Market by Sector, Segment & Applications - Forecasts to 2017
M2 - Tue Apr 01, 8:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kss73x/latin_american) has announced the addition of the "Latin American Bioinformatics Market by Sector, Segment & Application - Forecasts to 2017" report to their offering. The Latin American bioinformatics market displays a lucrative growth potential. It is estimated to grow at a CAGR of 22% from 2012 to 2017 to reach $627 million by 2017 In Latin America, bioinformatics is now widely recognized as a crucial field for research and development in agricultural, veterinary, and human health sciences. The growth of the bioinformatics market is driven by factors such as the decreasing cost of DNA sequencing, the increasing number of training and development programs on the usage of bioinformatics tools/platforms, the high concentration of bioinformatics research institutes, ongoing partnerships of academic institutions, and the formation of regional bioinformatics networks. However, the dearth of adequate infrastructural facilities and skilled professionals, presence of obsolete bioinformatics solutions, lack of government funding and investments, and less focus of global bioinformatics players on Latin American countries are factors that are restraining the growth of the market. Based on the use of bioinformatics in various industries, the bioinformatics market is segmented into agriculture, medical, environment, forensic, academics, and others (including homeland security and defense, law-enforcement groups, bioweapon creation, antibiotic resistance, and evolutionary biotechnology). The medical biotechnology market is segmented into molecular medicine, clinical diagnostics, drug development, gene therapy, and reproductive biotechnology. On the other hand, agriculture biotechnology is segmented into crop yield improvement, insect and disease resistance, nutritional quality improvement, soil quality improvement, improvement of plant resistance against abiotic stress, and others. Furthermore, the environmental biotechnology market includes waste cleanup, alternative energy sources, climate change studies, forensics biotechnology, and others. Based on the type of products and services, the bioinformatics market is classified into knowledge management tools, platforms, and services. The bioinformatics knowledge management tools market includes generalized and specialized knowledge management tools. The bioinformatics platforms market is segmented into sequence analysis platforms, sequence alignment platforms, sequence manipulation platforms, structural and functional analysis platforms, and others. The bioinformatics services market comprises sequencing services, database management, data analysis, and others. The bioinformatics market has several practical applications in fields that generate large data sets. In this report, the various applications of bioinformatics include genomics, proteomics, chemoinformatics, molecular phylogenies, metabolomics, transcriptomics, and others. Brazil was the largest market in 2012 with 40% share of the Latin American bioinformatics market, followed by Mexico. However, Chile and Peru represent the fastest-growing markets due to the initiatives taken by these nations with regards to skills development of researchers as well as the ongoing academic collaborations to facilitate the adoption of bioinformatics in life sciences research. The major players in the bioinformatics industry include Agilent Technologies, Inc. (U.S.), Affymetrix, Inc. (U.S.), Life Technologies Corporation (U.S.), Illumina, Inc. (U.S.), and CLC Bio (Denmark). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Latin America Bioinformatics Market, By Sectors 6 Latin America Bioinformatics Market, By Products & Services 7 Latin America Bioinformatics Market, By Applications 8 Geographic Analysis 9 Company Profiles - Accelrys, Inc. - Active Motif, Inc. - Affymetrix, Inc. - Agilent Technologies, Inc. - Clc Bio - Geneva Bioinfromatics (Genebio) Sa - Illumina, Inc. - Life Technologies Corporation - Partek, Incorporated - Perkinelmer, Inc. For more information visit http://www.researchandmarkets.com/research/ks...n_american
Top Gainers Updates -- Research on Sangamo BioSciences, Synthesis Energy Systems, OXiGENE, and Affymetrix
PR Newswire - Tue Apr 01, 8:08AM CDT
On Monday, March 31, 2014, the US markets saw a positive sentiment, as the NASDAQ Composite closed at 4,198.99, up 1.04%, the Dow Jones Industrial Average ended the session at 16,457.66, up 0.82% and the S&P 500 edged 0.79% higher to finish the trading session at 1,872.34. The gains were broad based as nine out of 10 sectors ended the session in positive. A number of stocks saw large movements, including Sangamo BioSciences Inc. (NASDAQ: SGMO), Synthesis Energy Systems Inc. (NASDAQ: SYMX), OXiGENE Inc. (NASDAQ: OXGN) and Affymetrix Inc. (NASDAQ: AFFX). Free technical research on SGMO, SYMX, OXGN and AFFX can be downloaded upon signing up at:
Shares of AFFX Down 9.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 31, 9:28AM CDT
SmarTrend identified a Downtrend for Affymetrix (NASDAQ:AFFX) on February 6th, 2014 at $7.53. In approximately 2 months, Affymetrix has returned 9.63% as of today's recent price of $6.80.
Global Biochips Market 2012-2016: Major Challenge for Market is High Cost Incurred in the Implementation of Biochips
M2 - Thu Mar 20, 11:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bcvpcl/global_biochips) has announced the addition of the "Global Biochips Market 2012-2016" report to their offering. The analysts forecast the Global Biochips market to grow at a CAGR of 19.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing need for high speed diagnosis. The Global Biochips market has also been witnessing the high cost of deployment. However, the increasing outsourcing activities could pose a challenge to the growth of this market. Key vendors dominating this space include Affymetrix Inc., Illumina, Inc., GE Healthcare Ltd. and Agilent Technologies Inc. Other vendors mentioned in the report are Bio-Rad Laboratories Inc., Biomrieux Sa, Caliper Life Sciences Inc., Cephied Inc., Fluidigm Corp., Life Technologies Corp., Cybrdi Inc., Gamida For Life Group, Origene Technologies Inc., Perkinelmer Inc., Roche Nimblegen Inc., Sigma Aldrich Corp, Isu Abxis Co. Ltd, and Us Biomax Inc. Commenting on the report, an analyst from the Hardware team said: ''Over the years, numerous drug manufacturers have been outsourcing their drug development processes to contract research organizations. Outsourcing activities reduce manufacturing and distribution costs, ensure quality of service, and reduce lead time. They also help the sourcing companies to manage product demand and to concentrate on other competencies such as innovation and brand building. These contract research organizations employ the latest technologies and sophisticated instruments, and thus increased outsourcing to such organizations is a positive trend for the Global Biochips market.'' According to the report, one of the major drivers is the growing need for high speed diagnosis from patients and doctors. Biochips are specially designed with advanced technology that makes them ultra-efficient, therefore, enhancing their operating speed to a great extent. For more information visit http://www.researchandmarkets.com/research/bc...l_biochips About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Specialty Enzymes Market by Source, Type, Application & Geography - Global Trends & Forecasts to 2018
M2 - Thu Mar 20, 3:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cpjrtc/specialty_enzymes) has announced the addition of the "Specialty Enzymes Market by Source, Type, Application & Geography - Global Trends & Forecasts to 2018" report to their offering. Specialty enzymes are natural proteins produced from micro organisms, plants and animals. An enzyme serves as catalysts for the chemical process that include the production of pharmaceuticals, diagnostics, research & biotechnology, and biocatalytic solutions. Enzymes increase reaction rates by decreasing the amount of energy required to form a complex of reactants that is competent to produce reaction products. Specialty enzymes according to their type are classified as carbohydrases, proteases, polymerases and nucleases, lipases, and others. Specialty enzymes report covers analysis of the market structure by identifying various sub-segments of the global specialty enzymes market, Revenue forecasts of the global specialty enzymes markets and its various sub-markets/micro-markets with respect to four main regions- North America, Europe, Asia-Pacific, and Rest of the World (RoW). Major trends, drivers, and restraints of the global specialty enzymes market are identified and explained in detail. The specialty enzyme markets include pharmaceutical, research and biotechnology, diagnostics and biocatalysts. Pharmaceutical manufacturers are witnessing increased awareness in incorporating biocatalysis into manufacturing processes. Enzymes are particularly useful to generate isomerically pure pharmaceuticals and fine chemicals In spite of numerous advantages of biocatalysis, manufacturers have been slow to adopt industrial-scale enzymatic approaches. Key Topics Covered: Introduction Executive Summary Premium Insights Market Overview Global Specialty Enzymes Market, By Source Specialty Enzyme Market, By Type Specialty Enzyme Market, By Application Specialty Enzymes Market, By Geography Competitive Landscape Company Profiles List of Tables List of Figures Companies Mentioned - Advanced Enzyme Technology Ltd. - Affymetrix Inc. - Amano Enzyme Inc. - Basf - Bbi Enzymes Ltd. - Codexis Inc. - Life Technologies - Nagase & Co. Ltd. - Roche Holding Ag. - Sanofi S.A. For more information visit http://www.researchandmarkets.com/research/cp...ty_enzymes About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Imaging Biomarkers Market 2014-2018 with Abbott, Agilent, Affymetrix, Siemens, Bio-Rad & F. Hoffmann La Roche Dominating
M2 - Tue Mar 18, 10:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/brn9sx/global_imaging) has announced the addition of the "Global Imaging Biomarkers Market 2014-2018 with Abbott, Agilent, Affymetrix, Siemens, Bio-Rad & F. Hoffmann La Roche Dominating" report to their offering. The use of imaging biomarkers in the field of drug discovery has increased considerably over the past few years. The increase in the demand for imaging biomarkers is primarily because of their ability to be used in target discovery and validation, identification of disease mechanisms, toxicity profiling, and proof-of-concept studies. The Global Imaging Biomarkers market has been witnessing an increase in the number of strategic alliances being formed among organizations. Mergers and acquisitions help organizations grow rapidly, expand their business processes, and gain more market share. The introduction of innovative technologies by small and mid-sized companies is prompting major pharmaceutical and biotechnology companies to form strategic alliances with these smaller companies to identify various imaging biomarkers. The increase in strategic alliances is resulting in an increase in the application base for imaging biomarkers in drug discovery and diagnosis domains. For instance, in 2012, Genomic Health Inc. and OncoMed Pharmaceuticals announced a strategic alliance for Biomarker Research and Discovery using the Next-generation Sequencing process. Further, the report states that one of the main challenges hindering the growth of this market is the presence of poor regulatory and reimbursements systems. The current regulatory and reimbursement systems present in various countries are not well-suited for imaging biomarker-based diagnostics. The development of novel and useful imaging biomarkers is also an expensive and time-consuming process. The key vendors dominating this market space are: - Abbott Laboratories - Agilent Technologies Inc. - Affymetrix Inc. - Bio-Rad Laboratories Inc. - F. Hoffmann La Roche Ltd. - Gen-Probe Inc. - Siemens Healthcare. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Geographical Segmentation 08. Buying Criteria 09. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Trends and their Impact 15. Vendor Landscape 16. Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/br...al_imaging
Equine Healthcare Market Report, 2013 - 2019: Diagnostic Products, Therapeutic Products and Supplement Products
M2 - Fri Mar 14, 9:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qdnqld/equine_healthcare) has announced the addition of the "Equine Healthcare Market Report, 2013 - 2019: Diagnostic Products, Therapeutic Products and Supplement Products" report to their offering. The global equestrian market is a multi-billion dollar industry that comprises horse racing and betting, leisure and competitive riding and has spawned and supports multifarious secondary markets. The equine healthcare market ranks as one of the key secondary markets. This report exclusively studies the market for equine healthcare from varied aspects such as, equine diagnostic products, equine therapeutic products and equine supplement products. It is thus classified into three prime segments namely equine diagnostic products market, equine therapeutic products market and equine supplement products market. The market size and forecast for the period 2013-2019, in terms of USD million, considering 2012 as the base year has been provided for each segment and sub-segments in the report. The compound annual growth rate (CAGR) for each segment and sub-segments has been provided for the forecast period from 2013-2019. Scope of the Report Equine Diagnostic Products Market, by Type - Equine Pregnancy and Gestation Diagnostic Products Market -- Equine UltraSound Devices Market -- Equine Urine Test Kits Market - Equine Genotyping Analysis Products Market -- Breed Quality Analyzers/Genotype Analyzers Kits Market -- Genetic Disease Identification Products/Semen Quality Analyzers Market Equine Therapeutic Products Market, by Type - Equine Vaccines Market - Equine Antibacterials Market - Equine Antivirals Market - Equine Antiprotozoals Market - Equine Dopamine Agonists Market - Equine Anti-inflammatory Drugs Market - Equine Laxatives Market Equine Supplement Products Market, by Type - Equine Performance Supplements Market -- Equine Proteins and Amino Acids Supplements Market -- Equine Vitamin Supplements Market -- Equine Electrolyte Supplements Market -- Other Equine Performance Supplements Market - Equine Protection Products Market -- Equine Protection Products Market -- Equine Prosthetics Market Companies Mentioned - Affymetrix, Inc. - Bayer - Boerhringer Ingelheim Vetmedica, Inc. (BIVI) - Elanco Animal Health - Equine Diagnostics - Equine Orthotics and Prosthetics - Equine Products (UK) Ltd. - Merck Animal Health - Purina Mills, LLC - Signostics Limited - Zoetis, Inc. For more information visit http://www.researchandmarkets.com/research/qd...healthcare
Affymetrix (AFFX) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 9:40AM CDT
Affymetrix (AFFX) Sees Hammer Chart Pattern: Time to Buy?
CollabRx partners with Affymetrix to develop integrated clinical cancer panels
M2 - Thu Apr 17, 7:16AM CDT
CollabRx, Inc. (NASDAQ: CLRX) and Affymetrix, Inc. (NASDAQ: AFFX) said they have announced an agreement to optimize the use of CollabRx's Genetic Variant Annotation Service in connection with Affymetrix' OncoScan FFPE Assay Kit and CytoScan Cytogenetics Suite for analysis of gene copy number variation in cancer research.
CollabRx and Affymetrix Partner To Develop Analytical Tools For Integrated Clinical Cancer Panels
PRWeb - Wed Apr 16, 8:07AM CDT
CollabRx, Inc. (NASDAQ: CLRX), a leading provider of software and IT systems that support clinical decision-making in oncology, and Affymetrix, Inc. (NASDAQ: AFFX), an industry leader in genomics analysis, today announced an agreement to optimize the use of CollabRx's Genetic Variant Annotation (GVA) Service™ in connection with Affymetrix' OncoScan™ FFPE Assay Kit and CytoScan(R) Cytogenetics Suite for analysis of gene copy number variation (CNV) in cancer research.
Global SNP Genotyping and Analysis Market Forecasts & Opportunities 2013-2019
M2 - Mon Apr 14, 4:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bk2mlx/snp_genotyping) has announced the addition of the "Global SNP Genotyping and Analysis Market Forecasts & Opportunities 2013-2019" report to their offering. The global market is expected to reach USD 9,485.2 million by 2019, up from USD 2,385.2 million in 2012, growing at a CAGR of 21.8% The study elucidates the market dynamics, which are the drivers, restraints and opportunities that a market player will come across in this area. It gives a brief introduction to each topic as it covers the commercial aspects of the market and its technologies along with current trends. The report analyzes four major applications of SNP genotyping in Life Sciences and Healthcare industry which are Pharmaceutical/Pharmacogenomics, Diagnostics, Agricultural Biotechnology and Breeding and Animal Livestock. The market products are internally affected by power of substitution since there are around 8 to 10 different efficient techniques to carry out SNP genotyping such as TaqMan, SNPlex, Microarray, MALDI-TOF etc. With the completion of the Human Genome Project, over 2 million SNP's have been added to global databases which in turn have initiated a series of research and development projects to understand potential of developing diagnostic tests through rapid genotyping techniques. A considerable amount of revenue is spent on research to developing diagnostic products similar to companion diagnostics which would enable to give us a preview of how a genome would unfold as an individual grows older. There is a high intensity of research in food crops such as rice, wheat, oats, corn, maize and other grasses. SNP genotyping in agriculture gained acceptance long before other applications. The GeneChip Rice 44K array offered by Affymetrix is one of the most popular platforms for rice genotyping which identifies variants that impact yield. Fluidigm's SNPtype assays have been utilized by International Rice Research Institute which holds the world's largest ex-situ collection of rice germplasm and plays a very large role in maintaining this repository. Scope of the Report Technology - SNP GeneChips and Microarrays - Taqman Allelic Discrimination - SNP by Pyrosequencing - AB SNPlex - MassARRAY MALDI-TOF - Others Application - Pharmaceuticals and Pharmacogenomics - Diagnostic Research - Agricultural Biotechnology - Breeding and Animal Livestock Key Topics Covered: - Introduction - Executive Summary - Market Overview: Global SNP Genotyping & Analysis Market - Global SNP Genotyping & Analysis Market, by Technologies, 2011 - 2019 (USD Million) - Global SNP Genotyping and Analysis Market, by Applications, 2011 - 2019 (USD Million) - Global SNP Genotyping and Analysis Market, by Geography, 2011 - 2019 (USD Million) - Competitive Landscape - Company Profiles - Affymetrix, Inc - Douglas Scientific LLC - Fluidigm - Illumina, Inc - Life Technologies Corporation - PREMIER Biosoft - Sequenom, Inc - ThermoFisher Scientific Visit http://www.researchandmarkets.com/research/bk...genotyping
15.2% Return Seen to Date on SmarTrend Affymetrix Call (AFFX)
Comtex SmarTrend(R) - Fri Apr 11, 9:47AM CDT
SmarTrend identified a Downtrend for Affymetrix (NASDAQ:AFFX) on February 6th, 2014 at $7.53. In approximately 2 months, Affymetrix has returned 15.22% as of today's recent price of $6.38.
Awards, Conference Call Schedules, New Products, and Partnerships - Analyst Notes on Silicon Labs, Affymetrix, Methode Electronics, Itron, and Semtech
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Silicon Laboratories Inc. (NASDAQ: SLAB), Affymetrix Inc. (NASDAQ: AFFX), Methode Electronics Inc. (NYSE: MEI), Itron, Inc. (NASDAQ: ITRI), and Semtech Corp. (NASDAQ: SMTC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Global Proteomics Market (Technology, Instruments, Reagents & Services) - Global Forecast to 2018
M2 - Tue Apr 08, 6:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2hnkrt/proteomics_market) has announced the addition of the "Proteomics Market by Technology, Instruments, Reagents & Services - Global Forecast to 2018" report to their offering. The global market was valued at an estimated $10,223.3 million in 2013. The growth of this market is mainly fuelled by the increasing need for personalized medicine, growth in pharmaceutical and biotechnology research and development (R&D) expenditure, technological advancements, and availability of government and private funding for proteomics projects.The overall market is further divided into four major geographies, namely, North America, Europe, Asia, and the Rest of the World (RoW). These regions are further analyzed at the country level. This report discusses the key market drivers, restraints, and opportunities in the global proteomics market and its sub-markets. Based on reagents type, the market is segmented into protein microarray, spectroscopy, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation kits. Furthermore, the services market is sub-divided into analytical laboratory services, and data analysis and maintenance. Analytical laboratory services are further segmented into three types, namely, protein identification, protein separation, and protein sequencing. Data analysis and maintenance is further divided into bioinformatics databases and bioinformatics tools. North America accounted for the largest share of the global market in 2013, followed by Europe, Asia-Pacific, and the Rest of the World. Developed geographies like North America and Europe are likely to grow at lower CAGRs as compared to the Asian market. The growth in the Asian market is attributed to the shift of focus of the proteomics research-related industries towards Asia and the increase in both public and private funding to boost proteomic research in the region. Scope of the Report Proteomics Instrumentation Technologies - Protein Microarray - - Biochips - - Microarray instruments - Spectroscopy - - Mass spectrometry - - NMR spectrometry - - Circular dichroism (CD) spectroscopy - X-ray Crystallography - Chromatography - - HPLC Systems - - Affinity chromatography - - Ion chromatography - Supercritical Fluid Chromatography - Electrophoresis - - Gel electrophoresis - - Capillary electrophoresis - Surface Plasmon Resonance System (SPR System) - Protein Fractionation System Proteomics Reagents - Microarray - Spectroscopy - X-ray Crystallography - Chromatography - Electrophoresis - Immunoassay - Microsphere - Protein Fractionation Kits Proteomics Services - Analytical Laboratory Services - Protein Identification - Protein Separation - Protein Sequencing - Data Analysis and Maintenance - Bioinformatics Databases - Bioinformatics Tools - Global Proteomics Market, by Application - Drug Discovery - Diagnosis Key Topics Covered: - Introduction - Executive Summary - Premium Insights - Market Overview - Proteomics Instrumentation Technology - Proteomics Reagents Market - Proteomics Services Market - Proteomics Applications Market - Geographic Analysis - Competitive Landscape - Company Profiles - Thermo Fisher Scientific Inc. - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Luminex Corporation - Danaher Corporation - Ge Healthcare - Waters Corporation - Affymetrix Inc. - Perkinelmer, Inc. - Sigma-Aldrich Corp Visit http://www.researchandmarkets.com/research/2h...ics_market
Global Multiplexed Diagnostics Market (Technologies & Applications) 2013 - 2019
M2 - Tue Apr 08, 2:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m73r7s/multiplexed) has announced the addition of the "Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. This report covers the market analysis of the multiplexed diagnostics technologies namely, very high, high, medium, low density multiplexed assays & next-generation sequencing. This report contains qualitative information about oligonucleotide arrays, phage display, bacterial artificial chromosome arrays, protein arrays, bead-based arrays, antibody arrays, reverse arrays, mass spectrometry, quantitative PCR bead-based and microplate assays and next-generation sequencing. The market is also segmented on the basis of several application areas of multiplexed diagnostics, namely, infectious disease diagnosis, oncology, autoimmune diseases, cardiac conditions, allergies and others (Alzheimer's disease, diabetes, kidney toxicity and HIV). The global multiplexed diagnostics market has phenomenally increased the volume and quality of diagnostic procedures by reducing the turnaround time and analyzing multiple analytes in a single cycle and thereby resulting in rapid adoption of such techniques. The stake holders in this market include market players who provide multiplexed diagnostic assay kits, reagents, solutions and systems. The qualitative details of the market dynamics of the multiplexed diagnostics market such as drivers, restraints and opportunities that influence the current nature and future status of this field are covered under the market overview section of this report. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been provided in the market overview section of the report in order to give a thorough analysis of the overall competitive scenario in the global multiplexed diagnostics market. The market size and forecast in terms of USD million has been provided in the report for the period 2011 to 2019. This report also includes the overall market growth rate (Compounded Annual Growth Rate) of technologies, applications and geographic market for the period 2013 to 2019, considering 2012 as the base year. The global multiplexed diagnostics market is segmented as follows: Technology - Very high density multiplexed assays - - Oligonucleotide Arrays - - Phage Display - High Density Multiplexed Assays - - Bacterial Artificial Chromosome Arrays - - Protein Arrays - Medium Density Multiplexed Assays - - Bead-based Arrays - - Antibody Arrays - - Reverse Arrays - - Mass Spectroscopy - Low Density Multiplexed Arrays - - Quantitative PCR Bead-based Assays - - Microplate Assays - Next-Generation Sequencing Application - Infectious Disease Diagnosis - Oncology - Autoimmune diseases - Cardiac - Allergies - Others Key Topics Covered: - Introduction - Executive Summary - Multiplexed Diagnostics Market Overview - Global Multiplex Assays Market, by Technology - Global Multiplex Diagnostics Market, By Application - Global Multiplexed Diagnostics Market, by Geography - Recommendations - Company Profiles - Affymetrix, Inc. - Agilent Technologies, Inc. - bioMerieux, Inc. - Bio-Rad Laboratories, Inc. - Illumina, Inc. - F. Hoffman-La Roche, Ltd. - Gen-Probe, Inc. - Life Technologies Corporation - Luminex Corporation - Seegene, Inc. Visit http://www.researchandmarkets.com/research/m7...ultiplexed
Gene Expression Reagent Trends - Global Market Report 2014
M2 - Mon Apr 07, 10:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3lbtf8/gene_expression) has announced the addition of the "Gene Expression Reagent Trends" report to their offering. Gene Expression refers to the production of functional products, most commonly proteins, using information saved in a specific gene. Gene expression is a key process undertaken by all life forms, including unicellular as well as multicellular organisms, primarily for generating their macromolecular machinery. The report analyzes and presents an overview of Gene Expression Reagents market worldwide. Supported with 3 market data tables, the report provides a review of global market trends, and various strategic industry activities of major companies witnessed by the industry over the last few years. Key Topics Covered: 1. GENE EXPRESSION REAGENTS - AN OVERVIEW 2. RECENT INDUSTRY ACTIVITY - Sigma-Aldrich Inks Agreement with Olink Bioscience - Synpromics Receives Grant from Technology Strategy Board - Thermo Fisher Scientific to Acquire Life Technologies - Agilent Technologies Inks Licensing Agreement with SRI International - Agilent Technologies Inks Agreement with Roche - ZyGEM Corp Signs Agreement with Quanta BioSciences - Affymetrix Receives US FDA Clearance for Gene Profiling Reagents 3. PRODUCT LAUNCHES/TECHNOLOGICAL INNOVATIONS - Agilent Technologies Launches SureScanDx Microarray Scanner - Illumina Introduces Universal Real-Time PCR Reagent Portfolio - Life Technologies Introduces Compendia Oncomine? Next - Generation Sequencing Power Tools - Mirus Bio Develops TransIT-BrCa Transfection Reagent - Affymetrix Launches Axiom? Genotyping Arrays - Affymetrix Introduces SensationPlus FFPE Reagent Kit - Agilent Technologies Unveils Agilent SurePrint G3 Human Gene Expression v2 Microarray - Agilent Unveils Agilent CytoGenomics 1.0 - Agilent Technologies Introduces GeneSpring GX 11. - Bioinformatics Software - Agilent Technologies Unveils New Exon Analysis Solution 4. MARKET PARTICIPANTS - Affymetrix, Inc. - Agendia, Inc. - Agilent Technologies, Inc. - Applied Biosystems, Inc. - Cepheid - Clontech Laboratories, Inc. - Complete Genomics, Inc. - Cytocell Ltd. - DNA LandMarks, Inc. - DNAVision SA - Dynex Technologies, Inc. - Epicentre? Biotechnologies - Eurofins Medigenomix GmbH - Eurogentec SA - Exiqon A/S - GE Healthcare - Geneworks Pty., Ltd. - Genisphere LLC - Illumina, Inc. - Inqaba Biotechnical Industries Pty., Ltd. - Life Technologies Corporation - Mirus Bio LLC - Ocimum Biosolutions Ltd. - Origene Technologies, Inc. - Quanta Biosciences, Inc. - Roche Diagnostics - Saturn Biotech Ltd. - Sequetech Corporation - Sigma-Aldrich Co. LLC - Thermo Fisher Scientific, Inc. 5. APPENDIX For more information visit http://www.researchandmarkets.com/research/3l...expression
DNA Gene Chip Trends - Global Market Overview 2014
M2 - Mon Apr 07, 10:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c4hnrx/dna_gene_chip) has announced the addition of the "DNA Gene Chip Trends" report to their offering. DNA Gene chips or DNA microarrays are small chips that are engrafted with DNA molecules. The versatile and powerful arrays are commonly used in medicinal and genetics research due to their ability to speed up the process of research. The primary research applications include geneID, comparative genomic hybridization, profiling of gene expression as well as re-sequencing and genotyping in human, plant, prokaryotes and eukaryotes genomes. The report analyzes and presents an overview of DNA & Gene Chip market worldwide. The report in addition provides global market estimates and projections for DNA & Gene Chip (Microarray) in US dollars for years 2012 through 2017. Supported with 6 market data tables the report provides a review of market trends, types and applications DNA microarrays, the current research scenario, and alternative competitive technologies. Key Topics Covered: 1. DNA GENE CHIPS - ACCELERATING MEDICINAL AND GENETIC RESEARCH - DNA Gene Chip - An Introduction - Types of DNA Microarrays - oDNA Microarrays - Spotted cDNA Microarrays - List of Major Applications of Microarrays - Advantages of Microarray Analysis - Top 5 Major Microarray Application Areas with Increasing Demand - DNA Gene Chip Market 2. RESEARCH SCENARIO - Technological Advancements in Biological Analysis - Mitochondrial DNA Microarray for Cancer Detection - Equine Gene Chip - Opens New Possibilities in Preventive Medication 3. COMPETITIVE ALTERNATIVE TECHNOLOGIES - Next Generation Sequencing (NGS) - NGS Technologies Application Areas - Present NGS Platforms - NGS - Key Facts 4. RECENT INDUSTRY ACTIVITY - Thermo Fisher Scientific to Take Over Life Technologies 5. MARKET PARTICIPANTS - Affymetrix, Inc. - Agilent Technologies, Inc. - Applied Microarrays, Inc. - Arrayit Corporation - Biometrix Technology, Inc. - Bioneer Corporation - Bio-Synthesis, Inc. - DNA Chip Research, Inc. - DNAmicroarray, Inc. - Eppendorf AG - Eurofins MWG Operon - Exiqon A/S - Genisphere LLC - Greiner Bio-One GmbH - Illumina, Inc. - LC Sciences - Macrogen, Inc. - Microarrays, Inc. - NGK Insulators Ltd. - Ocimum Biosolutions Ltd. - Oxford Gene Technology - PamGene International BV - PerkinElmer, Inc. - Savyon Diagnostics Ltd. - Scienion AG - Thermo Fisher Scientific, Inc. - Life Technologies Corporation - Toray Industries, Inc. - Toray International UK Ltd. - Toshiba Corporation 6. APPENDIX For more information visit http://www.researchandmarkets.com/research/c4..._gene_chip
Global Genomics Market Forecasts & Opportunities to 2018 - Products, Consumables & Services
M2 - Mon Apr 07, 3:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b5sp23/genomics_market) has announced the addition of the "Global Genomics Market Forecasts & Opportunities to 2018 - Products, Consumables & Services" report to their offering. The global genomics market was valued at $11.11 billion in 2013, and is expected to grow at a CAGR of over 12.0% from 2013 to 2018. The penetration of new markets through the expansion of genomics applications, and advancements in existing technologies plays an important role in attracting new market participants to invest in this market. Next Generation Sequencing (NGS) in personalized medicine and molecular diagnostics is considered as a high growth area for the global genomics market. This new technology provides an affordable and accurate screening solution for genetic mutations. Moreover, the increasing volume of novel genetic tests for personalized medicine and biomarker discovery ensures the continued growth of this market. Tier I and Tier II companies were found to be dominant in the instrument and consumables segments of the genomics market. The genomics market is becoming increasingly consolidated. Among all market players, Roche Diagnostics, Life Technologies, and QIAGEN together accounted for over 47.0% of the revenues earned by the global genomics market in 2013. This concentration of market shares with Tier I market players is expected to challenge market growth. However, technological advancements, and increasing investments are expected to continue to drive the growth of the global genomics market. This report provides comprehensive analysis of market dynamics - drivers, restraints, key market metrics, current market trends, competitive structure, and market revenues and forecasts from 2013 to 2018. It also includes an analysis of mergers and acquisitions in the global genomics market over the last ten years, in addition to technology roadmaps for key technology areas in this market. As a part of the premium insights section, current growth strategies adopted by market participants in the global genomics market have been detailed and analyzed. Scope Products - Instruments - NGS platform - Microarray - RT-PCR Consumables - Genechips - Reagents for DNA Extraction & Purification - Sequencing Services - Sequencing & Microarray Services - Software) Key Topics Covered: - Introduction - Executive Overview - Total Global Genomics Market - Global Genomics Market, By Product Segment - Global Genomics Market, By Technology - Global Genomics Market, By Application - Global Genomics Market, By Geography - Mergers And Acquisitions - Competitive Strategies - Company Profiles - Affymetrix, Inc. - Agilent Technologies, Inc. - Bgi - Bio-Rad Laboratories, Inc. - Cepheid - Ge Healthcare - Illumina, Inc. - Life Technologies, Corp. - Qiagen - Roche Diagnostics For more information visit http://www.researchandmarkets.com/research/b5...ics_market
Affymetrix to Report First Quarter 2014 Operating Results on Thursday May 1st, 2014
Business Wire - Wed Apr 02, 5:00AM CDT
Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will report operating results for the first quarter of 2014 after market close on Thursday May 1, 2014. The company will hold a conference call on the same day at 5:00pm ET.
Latin American Bioinformatics Market by Sector, Segment & Applications - Forecasts to 2017
M2 - Tue Apr 01, 8:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kss73x/latin_american) has announced the addition of the "Latin American Bioinformatics Market by Sector, Segment & Application - Forecasts to 2017" report to their offering. The Latin American bioinformatics market displays a lucrative growth potential. It is estimated to grow at a CAGR of 22% from 2012 to 2017 to reach $627 million by 2017 In Latin America, bioinformatics is now widely recognized as a crucial field for research and development in agricultural, veterinary, and human health sciences. The growth of the bioinformatics market is driven by factors such as the decreasing cost of DNA sequencing, the increasing number of training and development programs on the usage of bioinformatics tools/platforms, the high concentration of bioinformatics research institutes, ongoing partnerships of academic institutions, and the formation of regional bioinformatics networks. However, the dearth of adequate infrastructural facilities and skilled professionals, presence of obsolete bioinformatics solutions, lack of government funding and investments, and less focus of global bioinformatics players on Latin American countries are factors that are restraining the growth of the market. Based on the use of bioinformatics in various industries, the bioinformatics market is segmented into agriculture, medical, environment, forensic, academics, and others (including homeland security and defense, law-enforcement groups, bioweapon creation, antibiotic resistance, and evolutionary biotechnology). The medical biotechnology market is segmented into molecular medicine, clinical diagnostics, drug development, gene therapy, and reproductive biotechnology. On the other hand, agriculture biotechnology is segmented into crop yield improvement, insect and disease resistance, nutritional quality improvement, soil quality improvement, improvement of plant resistance against abiotic stress, and others. Furthermore, the environmental biotechnology market includes waste cleanup, alternative energy sources, climate change studies, forensics biotechnology, and others. Based on the type of products and services, the bioinformatics market is classified into knowledge management tools, platforms, and services. The bioinformatics knowledge management tools market includes generalized and specialized knowledge management tools. The bioinformatics platforms market is segmented into sequence analysis platforms, sequence alignment platforms, sequence manipulation platforms, structural and functional analysis platforms, and others. The bioinformatics services market comprises sequencing services, database management, data analysis, and others. The bioinformatics market has several practical applications in fields that generate large data sets. In this report, the various applications of bioinformatics include genomics, proteomics, chemoinformatics, molecular phylogenies, metabolomics, transcriptomics, and others. Brazil was the largest market in 2012 with 40% share of the Latin American bioinformatics market, followed by Mexico. However, Chile and Peru represent the fastest-growing markets due to the initiatives taken by these nations with regards to skills development of researchers as well as the ongoing academic collaborations to facilitate the adoption of bioinformatics in life sciences research. The major players in the bioinformatics industry include Agilent Technologies, Inc. (U.S.), Affymetrix, Inc. (U.S.), Life Technologies Corporation (U.S.), Illumina, Inc. (U.S.), and CLC Bio (Denmark). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Latin America Bioinformatics Market, By Sectors 6 Latin America Bioinformatics Market, By Products & Services 7 Latin America Bioinformatics Market, By Applications 8 Geographic Analysis 9 Company Profiles - Accelrys, Inc. - Active Motif, Inc. - Affymetrix, Inc. - Agilent Technologies, Inc. - Clc Bio - Geneva Bioinfromatics (Genebio) Sa - Illumina, Inc. - Life Technologies Corporation - Partek, Incorporated - Perkinelmer, Inc. For more information visit http://www.researchandmarkets.com/research/ks...n_american
Top Gainers Updates -- Research on Sangamo BioSciences, Synthesis Energy Systems, OXiGENE, and Affymetrix
PR Newswire - Tue Apr 01, 8:08AM CDT
On Monday, March 31, 2014, the US markets saw a positive sentiment, as the NASDAQ Composite closed at 4,198.99, up 1.04%, the Dow Jones Industrial Average ended the session at 16,457.66, up 0.82% and the S&P 500 edged 0.79% higher to finish the trading session at 1,872.34. The gains were broad based as nine out of 10 sectors ended the session in positive. A number of stocks saw large movements, including Sangamo BioSciences Inc. (NASDAQ: SGMO), Synthesis Energy Systems Inc. (NASDAQ: SYMX), OXiGENE Inc. (NASDAQ: OXGN) and Affymetrix Inc. (NASDAQ: AFFX). Free technical research on SGMO, SYMX, OXGN and AFFX can be downloaded upon signing up at:
Shares of AFFX Down 9.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 31, 9:28AM CDT
SmarTrend identified a Downtrend for Affymetrix (NASDAQ:AFFX) on February 6th, 2014 at $7.53. In approximately 2 months, Affymetrix has returned 9.63% as of today's recent price of $6.80.
Global Biochips Market 2012-2016: Major Challenge for Market is High Cost Incurred in the Implementation of Biochips
M2 - Thu Mar 20, 11:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bcvpcl/global_biochips) has announced the addition of the "Global Biochips Market 2012-2016" report to their offering. The analysts forecast the Global Biochips market to grow at a CAGR of 19.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing need for high speed diagnosis. The Global Biochips market has also been witnessing the high cost of deployment. However, the increasing outsourcing activities could pose a challenge to the growth of this market. Key vendors dominating this space include Affymetrix Inc., Illumina, Inc., GE Healthcare Ltd. and Agilent Technologies Inc. Other vendors mentioned in the report are Bio-Rad Laboratories Inc., Biomrieux Sa, Caliper Life Sciences Inc., Cephied Inc., Fluidigm Corp., Life Technologies Corp., Cybrdi Inc., Gamida For Life Group, Origene Technologies Inc., Perkinelmer Inc., Roche Nimblegen Inc., Sigma Aldrich Corp, Isu Abxis Co. Ltd, and Us Biomax Inc. Commenting on the report, an analyst from the Hardware team said: ''Over the years, numerous drug manufacturers have been outsourcing their drug development processes to contract research organizations. Outsourcing activities reduce manufacturing and distribution costs, ensure quality of service, and reduce lead time. They also help the sourcing companies to manage product demand and to concentrate on other competencies such as innovation and brand building. These contract research organizations employ the latest technologies and sophisticated instruments, and thus increased outsourcing to such organizations is a positive trend for the Global Biochips market.'' According to the report, one of the major drivers is the growing need for high speed diagnosis from patients and doctors. Biochips are specially designed with advanced technology that makes them ultra-efficient, therefore, enhancing their operating speed to a great extent. For more information visit http://www.researchandmarkets.com/research/bc...l_biochips About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Specialty Enzymes Market by Source, Type, Application & Geography - Global Trends & Forecasts to 2018
M2 - Thu Mar 20, 3:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cpjrtc/specialty_enzymes) has announced the addition of the "Specialty Enzymes Market by Source, Type, Application & Geography - Global Trends & Forecasts to 2018" report to their offering. Specialty enzymes are natural proteins produced from micro organisms, plants and animals. An enzyme serves as catalysts for the chemical process that include the production of pharmaceuticals, diagnostics, research & biotechnology, and biocatalytic solutions. Enzymes increase reaction rates by decreasing the amount of energy required to form a complex of reactants that is competent to produce reaction products. Specialty enzymes according to their type are classified as carbohydrases, proteases, polymerases and nucleases, lipases, and others. Specialty enzymes report covers analysis of the market structure by identifying various sub-segments of the global specialty enzymes market, Revenue forecasts of the global specialty enzymes markets and its various sub-markets/micro-markets with respect to four main regions- North America, Europe, Asia-Pacific, and Rest of the World (RoW). Major trends, drivers, and restraints of the global specialty enzymes market are identified and explained in detail. The specialty enzyme markets include pharmaceutical, research and biotechnology, diagnostics and biocatalysts. Pharmaceutical manufacturers are witnessing increased awareness in incorporating biocatalysis into manufacturing processes. Enzymes are particularly useful to generate isomerically pure pharmaceuticals and fine chemicals In spite of numerous advantages of biocatalysis, manufacturers have been slow to adopt industrial-scale enzymatic approaches. Key Topics Covered: Introduction Executive Summary Premium Insights Market Overview Global Specialty Enzymes Market, By Source Specialty Enzyme Market, By Type Specialty Enzyme Market, By Application Specialty Enzymes Market, By Geography Competitive Landscape Company Profiles List of Tables List of Figures Companies Mentioned - Advanced Enzyme Technology Ltd. - Affymetrix Inc. - Amano Enzyme Inc. - Basf - Bbi Enzymes Ltd. - Codexis Inc. - Life Technologies - Nagase & Co. Ltd. - Roche Holding Ag. - Sanofi S.A. For more information visit http://www.researchandmarkets.com/research/cp...ty_enzymes About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Imaging Biomarkers Market 2014-2018 with Abbott, Agilent, Affymetrix, Siemens, Bio-Rad & F. Hoffmann La Roche Dominating
M2 - Tue Mar 18, 10:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/brn9sx/global_imaging) has announced the addition of the "Global Imaging Biomarkers Market 2014-2018 with Abbott, Agilent, Affymetrix, Siemens, Bio-Rad & F. Hoffmann La Roche Dominating" report to their offering. The use of imaging biomarkers in the field of drug discovery has increased considerably over the past few years. The increase in the demand for imaging biomarkers is primarily because of their ability to be used in target discovery and validation, identification of disease mechanisms, toxicity profiling, and proof-of-concept studies. The Global Imaging Biomarkers market has been witnessing an increase in the number of strategic alliances being formed among organizations. Mergers and acquisitions help organizations grow rapidly, expand their business processes, and gain more market share. The introduction of innovative technologies by small and mid-sized companies is prompting major pharmaceutical and biotechnology companies to form strategic alliances with these smaller companies to identify various imaging biomarkers. The increase in strategic alliances is resulting in an increase in the application base for imaging biomarkers in drug discovery and diagnosis domains. For instance, in 2012, Genomic Health Inc. and OncoMed Pharmaceuticals announced a strategic alliance for Biomarker Research and Discovery using the Next-generation Sequencing process. Further, the report states that one of the main challenges hindering the growth of this market is the presence of poor regulatory and reimbursements systems. The current regulatory and reimbursement systems present in various countries are not well-suited for imaging biomarker-based diagnostics. The development of novel and useful imaging biomarkers is also an expensive and time-consuming process. The key vendors dominating this market space are: - Abbott Laboratories - Agilent Technologies Inc. - Affymetrix Inc. - Bio-Rad Laboratories Inc. - F. Hoffmann La Roche Ltd. - Gen-Probe Inc. - Siemens Healthcare. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Geographical Segmentation 08. Buying Criteria 09. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Trends and their Impact 15. Vendor Landscape 16. Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/br...al_imaging
Equine Healthcare Market Report, 2013 - 2019: Diagnostic Products, Therapeutic Products and Supplement Products
M2 - Fri Mar 14, 9:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qdnqld/equine_healthcare) has announced the addition of the "Equine Healthcare Market Report, 2013 - 2019: Diagnostic Products, Therapeutic Products and Supplement Products" report to their offering. The global equestrian market is a multi-billion dollar industry that comprises horse racing and betting, leisure and competitive riding and has spawned and supports multifarious secondary markets. The equine healthcare market ranks as one of the key secondary markets. This report exclusively studies the market for equine healthcare from varied aspects such as, equine diagnostic products, equine therapeutic products and equine supplement products. It is thus classified into three prime segments namely equine diagnostic products market, equine therapeutic products market and equine supplement products market. The market size and forecast for the period 2013-2019, in terms of USD million, considering 2012 as the base year has been provided for each segment and sub-segments in the report. The compound annual growth rate (CAGR) for each segment and sub-segments has been provided for the forecast period from 2013-2019. Scope of the Report Equine Diagnostic Products Market, by Type - Equine Pregnancy and Gestation Diagnostic Products Market -- Equine UltraSound Devices Market -- Equine Urine Test Kits Market - Equine Genotyping Analysis Products Market -- Breed Quality Analyzers/Genotype Analyzers Kits Market -- Genetic Disease Identification Products/Semen Quality Analyzers Market Equine Therapeutic Products Market, by Type - Equine Vaccines Market - Equine Antibacterials Market - Equine Antivirals Market - Equine Antiprotozoals Market - Equine Dopamine Agonists Market - Equine Anti-inflammatory Drugs Market - Equine Laxatives Market Equine Supplement Products Market, by Type - Equine Performance Supplements Market -- Equine Proteins and Amino Acids Supplements Market -- Equine Vitamin Supplements Market -- Equine Electrolyte Supplements Market -- Other Equine Performance Supplements Market - Equine Protection Products Market -- Equine Protection Products Market -- Equine Prosthetics Market Companies Mentioned - Affymetrix, Inc. - Bayer - Boerhringer Ingelheim Vetmedica, Inc. (BIVI) - Elanco Animal Health - Equine Diagnostics - Equine Orthotics and Prosthetics - Equine Products (UK) Ltd. - Merck Animal Health - Purina Mills, LLC - Signostics Limited - Zoetis, Inc. For more information visit http://www.researchandmarkets.com/research/qd...healthcare
